0001562180-24-000607.txt : 20240125
0001562180-24-000607.hdr.sgml : 20240125
20240125160302
ACCESSION NUMBER: 0001562180-24-000607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240124
FILED AS OF DATE: 20240125
DATE AS OF CHANGE: 20240125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Costa Carlos
CENTRAL INDEX KEY: 0001939167
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 24562155
MAIL ADDRESS:
STREET 1: C/O FOGHORN THERAPEUTICS INC.
STREET 2: 500 TECHNOLOGY SQUARE, SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-24
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001939167
Costa Carlos
500 TECHNOLOGY SQUARE
STE #700
CAMBRIDGE
MA
02139
false
true
false
false
Chief People Officer
false
Stock Option (right to buy)
3.06
2024-01-24
4
A
false
90000.00
3.06
A
2034-01-23
Common Stock
90000.00
90000.00
D
The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
/s/ Michael LaCascia, Attorney-in-Fact for Carlos Costa
2024-01-25